A method for the production of a monoclonal antibody to CD20 for the treatment of B-cell lymphoma

Details for Australian Patent Application No. 2006250888 (hide)

International Classifications

Event Publications

20 December 2007 PCT application entered the National Phase

PCT publication WO2006/126069 Priority application(s): WO2006/126069

17 April 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Mar 2008

24 April 2008 Alteration of Name

The name of the applicant has been altered to Avesthagen Limited

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.